These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2942521)
61. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reversed by the dietary antioxidant vitamin E. Beharka AA; Wu D; Han SN; Meydani SN Mech Ageing Dev; 1997 Feb; 93(1-3):59-77. PubMed ID: 9089571 [TBL] [Abstract][Full Text] [Related]
62. Thymosin-like peptides as potential immunostimulants. Synthesis via the polymeric-reagent method. Mokotoff M; Zhao M; Roth SM; Shelley JA; Slavoski JN; Kouttab NM J Med Chem; 1990 Jan; 33(1):354-60. PubMed ID: 1688622 [TBL] [Abstract][Full Text] [Related]
63. Effect of thymosin on cellular immunity in old age. Cowan MJ; Fujiwara P; Wara DW; Ammann AJ Mech Ageing Dev; 1981 Jan; 15(1):29-39. PubMed ID: 6456383 [TBL] [Abstract][Full Text] [Related]
64. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosin alpha-1. Roy R; Singh SM; Shanker A; Sodhi A Int J Immunopharmacol; 2000 Apr; 22(4):309-21. PubMed ID: 10689104 [TBL] [Abstract][Full Text] [Related]
65. Protective activity of thymosin alpha 1 against tumor progression in immunosuppressed mice. Ishitsuka H; Umeda Y; Sakamoto A; Yagi Y Adv Exp Med Biol; 1983; 166():89-100. PubMed ID: 6650286 [TBL] [Abstract][Full Text] [Related]
66. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma. Wolf GT; Peterson KA; Lovett EJ Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957 [TBL] [Abstract][Full Text] [Related]
67. Influence of pain stimulation on interleukin-2 production in mice. Fujiwara R; Yokoyama MM Ann N Y Acad Sci; 1994 Nov; 741():244-51. PubMed ID: 7825812 [TBL] [Abstract][Full Text] [Related]
68. The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five). Talmadge JE; Benedict KL; Uithoven KA; Lenz BF Immunopharmacology; 1984 Feb; 7(1):17-26. PubMed ID: 6232241 [TBL] [Abstract][Full Text] [Related]
69. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice. Paul S; Sodhi A Immunol Lett; 2002 Jul; 82(3):171-82. PubMed ID: 12036599 [TBL] [Abstract][Full Text] [Related]
70. Thymosin alpha-1 enhances the fertilizing capacity of human sperm cell: implication in diagnosis and treatment of male infertility. Naz RK; Kaplan P; Goldstein AL Biol Reprod; 1992 Dec; 47(6):1064-72. PubMed ID: 1493170 [TBL] [Abstract][Full Text] [Related]
71. In vivo effect of prothymosin-alpha 1 on humoral and cell-mediated immune responses in the young rat. Marić D; Veljić J; Ranin J; Janković BD Int J Neurosci; 1991 Jul; 59(1-3):135-42. PubMed ID: 1837789 [TBL] [Abstract][Full Text] [Related]
72. Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes. Kokkinopoulos D; Perez S; Baxevanis C; Papamichail M Immunopharmacol Immunotoxicol; 1987; 9(4):409-19. PubMed ID: 2893819 [TBL] [Abstract][Full Text] [Related]
73. A radioimmunoassay for thymosin alpha-1. Incefy GS; Ishimura K; Wang JG; Unson CG; Erickson BW J Immunol Methods; 1986 May; 89(1):9-17. PubMed ID: 3701071 [TBL] [Abstract][Full Text] [Related]
74. Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high-performance liquid chromatography. Low TL; McClure JE; Naylor PH; Spangelo BL; Goldstein AL J Chromatogr; 1983 Aug; 266():533-44. PubMed ID: 6630360 [TBL] [Abstract][Full Text] [Related]
75. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense. Thomas PT; House RV; Bhargava HN Life Sci; 1993; 53(18):1417-27. PubMed ID: 8231630 [TBL] [Abstract][Full Text] [Related]
76. Thymosin modulation of regulatory T cell function. Mutchnick MG; Prieto JA; Schaffner JA; Weller FE Clin Immunol Immunopathol; 1982 Jun; 23(3):626-33. PubMed ID: 6214350 [No Abstract] [Full Text] [Related]
77. Mixed interleukins and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated aged mice. Hadden EM; Malec P; Sosa M; Hadden JW Cell Immunol; 1992 Oct; 144(1):228-36. PubMed ID: 1394439 [TBL] [Abstract][Full Text] [Related]
78. Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. Rasi G; Silecchia G; Sinibaldi-Vallebona P; Spaziani E; Pierimarchi P; Sivilia M; Tremiterra S; Garaci E Int J Cancer; 1994 Jun; 57(5):701-5. PubMed ID: 8194879 [TBL] [Abstract][Full Text] [Related]
79. Antigenic specificity of a rabbit antiserum raised against the 15-28 segment of thymosin alpha 1. Ishimura K; Incefy GS; Wang JG; Komiyama T; Heimer EP; Felix AM; Unson CG; Khan SA; Erickson BW Mol Immunol; 1986 Jul; 23(7):701-7. PubMed ID: 2432409 [TBL] [Abstract][Full Text] [Related]
80. Thymosin alpha 11: a peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5. Caldarella J; Goodall GJ; Felix AM; Heimer EP; Salvin SB; Horecker BL Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7424-7. PubMed ID: 6369316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]